Study To Evaluate Pf-04965842 In Subjects With Moderate To Severe Atopic Dermatitis

PHASE2CompletedINTERVENTIONAL
Enrollment

269

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

March 31, 2017

Study Completion Date

April 30, 2017

Conditions
Atopic Dermatitis
Interventions
DRUG

PF-04965842

10 mg of PF-04965842 QD for 12 weeks

DRUG

PF-04965842

30 mg of PF-04965842 QD for 12 weeks

DRUG

PF-04965842

100 mg of PF-04965842 QD for 12 weeks

DRUG

PF-04965842

200 mg of PF-04965842 QD for 12 weeks

DRUG

Placebo

Placebo QD for 12 weeks

Trial Locations (64)

2035

Australian Clinical Research Network, Sydney

2606

Woden Dermatology, Phillip

3002

Sinclair Dermatology, East Melbourne

3050

Royal Melbourne Hospital, Parkville

3529

CRU Hungary Ltd., MISEK-CRU, Miskolc

4102

Veracity Clinical Research, Woolloongabba

4217

The Skin Centre, Benowa

5000

Allergo-Derm Bakos Kft., Szolnok

5073

North Eastern Health Specialists, Hectorville, South Australia

6000

Bacs Kiskun Megyei Korhaz, Bor es Nemibeteggondozo, Kecskemét

6160

Fremantle Dermatology, Fremantle

6720

Szegedi Tudomanyegyetem SzentGyorgyi Albert Klinikai Kozpont Borgyogyaszati es Allergologiai Klinika, Szeged

10075

Sadick Research Group, New York

10789

ISA GmbH, Berlin

11375

Forest Hills Dermatology Group, Forest Hills

15213

UPMC Department of Dermatology, Pittsburgh

18201

DermDox Centers for Dermatology, Hazleton

23233

West End Dermatology Associates, Richmond

23502

Virginia Clinical Research,Inc, Norfolk

23538

Universitaetsklinikum Schleswig-Holstein, Lübeck

30263

MedaPhase, Inc., Newnan

32073

Park Avenue Dermatology Administration Annex, Orange Park

Park Avenue Dermatology, Orange Park

32174

Leavitt Medical Associates of Florida d/b/a Ameriderm Research, Ormond Beach

32204

North Florida Dermatology Associates, PA, Jacksonville

33624

Forward Clinical Trials, Inc., Tampa

33756

Olympian Clinical Research, Clearwater

35209

Clinical Research Center of Alabama, Birmingham

40241

DS Research, Louisville

46168

The Indiana Clinical Trials Center, Plainfield

46256

Dawes Fretzin Clinical Research Group, LLC, Indianapolis

Dawes Fretzin Dermatology Group, LLC, Indianapolis

48084

Somerset Skin Centre, Troy

48149

Universitaetsklinikum Muenster, Münster

57702

Health Concepts, Rapid City

60118

Dundee Dermatology, West Dundee

64506

MediSearch Clinical Trials, Saint Joseph

70605

Shondra L Smith, MD Dermatology & Advanced Aesthetics, Lake Charles

72076

Universitaetsklinikum Tuebingen, Tübingen

74136

Vital Prospects Clinical Research Institute, P.C, Tulsa

77401

Bellaire Dermatology Associates, Bellaire

78218

Texas Dermatology and Laser Specialists, San Antonio

89119

Clinical Research Consortium, Las Vegas

90274

Peninsula Research Associates, Inc., Rolling Hills Estates

90404

Clinical Science Institute, Santa Monica

91105

Huntington Medical Foundation, Pasadena

92024

California Dermatology & Clinical Research Institute, Encinitas

92123

TCR Medical Corporation, San Diego

95819

Emil A. Tanghetti MD dba Center for Dermatology and Laser Surgery, Sacramento

06032

University of Connecticut Health Center (UConn Health), Farmington

08520

Psoriasis Treatment Center of Central New Jersey, East Windsor

07044

The Dermatology Group, P.C, Verona

02919

Clinical Partners, LLC, Johnston

V5Z 4E8

University of British Columbia, Vancouver

R3M 3Z4

Wiseman Dermatology Research Inc., Winnipeg

L3P 1X2

Lynderm Research Inc., Markham

L6J 7W5

Research by ICLS, Oakville

K9J 5K2

Skin Centre for Dermatology, Peterborough

L4B IA5

The Centre for Dermatology, Richmond Hill

N2J 1C4

K. Papp Clinical Research, Waterloo

N8W 5L7

Windsor Clinical Research Inc, Windsor

H2K 4L5

Innovaderm Research Inc., Montreal

G1V 4X7

Centre de Recherche Dermatologique du Quebec metropolitain (CRDQ), Québec

J1H 1Z1

Diex Research Sherbrooke Inc., Sherbrooke

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT02780167 - Study To Evaluate Pf-04965842 In Subjects With Moderate To Severe Atopic Dermatitis | Biotech Hunter | Biotech Hunter